Lipella Pharmaceuticals Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Lipella Pharmaceuticals Inc. (LIPO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-11-14
- Lipella Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- Lipella Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 0.00 shares.
- Lipella Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Lipella Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 55.00K shares.
- Lipella Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 53.00K shares, a 429.99% increase from fiscal 2022.
- Lipella Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 10.00K shares, a 98.62% decline from fiscal 2021.
- Lipella Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 726.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-14 | 0.00 shares 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 0.00 shares 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-14 | |||||
| 2024-12-31 | 55.00K shares 10-Q · filed 2025-11-14 | |||||
| 2024-03-31 | 55.00K shares 10-Q · filed 2024-11-14 | 440.00K shares 10-Q · filed 2024-05-09 | ||||
| 2023-12-31 | 53.00K shares 10-K · filed 2025-03-28 | 424.00K shares 10-K · filed 2024-02-27 | ||||
| 2023-06-30 | 424.00K shares 10-Q · filed 2023-11-14 | |||||
| 2022-12-31 | 10.00K shares 10-K · filed 2024-02-27 | |||||
| 2021-12-31 | 726.00K shares 10-K · filed 2023-03-31 |